12th Apr 2007 11:00
Bionostics PLC12 April 2007 11 April 2007 TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached (ii):Bionostics plc 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: ( ) An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : Yes. Restatement of historic interest in compliancewith the FSA's new disclosure and transparency rules 3. Full name of person(s) subject to the notification obligation (iii):Aviva plc and its subsidiaries 4. Full name of shareholder(s) (if different from 3.) (iv):BNY Norwich Union Nominees Limited 493,350*Chase GA Group Nominees Limited 1,337,360*Chase Nominees Limited 421,911*CUIM Nominees Limited 493,403*Vidacos Nominees Limited 29,192* * denotes direct interest 5. Date of the transaction (and date on which the threshold is crossed orreached if different) (v):N/A 6. Date on which issuer notified:2 March 2007 7. Threshold(s) that is/are crossed or reached:N/A 8. Notified details:................. A: Voting rights attached to shares Class/type of Situation Resulting situation after the triggering transaction (vii)shares previousif possible to the Triggering use transaction (vi) ISIN CODE Number Number Number of Number of voting % of voting rights of of voting shares rights (ix) Shares Rights Direct Direct (x) Indirect Direct Indirect (viii) (xi) OrdinaryShares GB0008381823 N/A N/A 2,475,216 2,475,216 None 4.91% None B: Financial InstrumentsResulting situation after the triggering transaction (xii) Type of Expiration Exercise/ Number of voting rights that may % offinancial date Conversion be acquired if the instument is votinginstrument (xiii) Period/Date exercised/converted rights (xiv) N/A Total (A+B) Number of voting rights % of voting rights2,475216 4.91% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable (xv):See Section 4 Proxy Voting: 10. Name of the proxy holder:See section 4 11. Number of voting rights proxy holder will cease to hold:................. 12. Date on which proxy holder will cease to hold voting rights:................. 13. Additional information:Figures are based on a total number of voting rights of 50,411,194. 14. Contact name:Simon Dighton, Bionostics PLC 15. Contact telephone number:01993 885070 Annex to Notification Of Major Interests In Shares (xvi) A: Identity of the person or legal entity subject to the notification obligation Full name (including legal form for legal entities):................. Contact address (registered office for legal entities):................. Phone number:................. Other useful information (at least legal representative for legal persons):................. B: Identity of the notifier, if applicable (xvii) Full name:................. Contact address:................. Phone number:................. Other useful information (e.g. functional relationship with the person or legalentity subject to the notification obligation):................. C: Additional information :................. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Aviva